| Elevated serum levels of the c-erbB-2 encoded oncoprotein fragment in cases of pure preeclampsia and HELLP syndrome. | None |
| Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. | None |
| Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. | None |
| Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form. | None |
| Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation. | None |
| In vivo effects of estrogens on c-erbB-2 oncoprotein levels in chorionic villous tissue and maternal serum. | None |
| Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas. | None |
| Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells. | None |
| Radioiodinated antibody targeting of the HER-2/neu oncoprotein. | None |
| The role of linoleic acid metabolism in the proliferative response of cells overexpressing the erbB-2/HER2 oncogene. | None |
| Effects of interfering and influencing factors on the analyses of p105 (c-erbB-2/HER-2) oncoprotein fragment in serum. | None |
| [Amplification and expression of c-erbB2 oncogene in normal, hyperplastic, and malignant endometria]. | None |
| [Expression of c-erbB-2 oncogene and mutation of p53 gene in myoepithelioma and myoepithelial carcinoma]. | None |
| An in vitro 1H-MRS model of oncogene transfection. The spectral feature of c-erbB-2 and c-Ha-ras transfected NIH3T3 fibroblast cells. | None |
| HER-2/neu oncogenic protein: issues in vaccine development. | None |
| A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein. | None |
| Mucoepidermoid carcinoma of the salivary gland--a clinico-pathologic and immunohistochemical study for c-erbB-2 oncoprotein. | None |
| Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. | None |
| The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene. | None |
| Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein. | None |